Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -23.00%-25.82M | ---- | -12.69%-20.99M | ---- | -51.48%-18.63M | ---- | 28.57%-12.3M | ---- | 35.54%-17.21M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -39.51%-226K | ---- | -422.58%-162K | ---- | -138.46%-31K | ---- | 56.67%-13K | ---- | 83.24%-30K |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 29.17%-408K | ---- | 45.30%-576K |
| Attributable subsidiary (profit) loss | ---- | -4.65%164K | ---- | 20.28%172K | ---- | -1.38%143K | ---- | 190.00%145K | ---- | --50K |
| Impairment and provisions: | ---- | 60.80%521K | ---- | -76.81%324K | ---- | 616.41%1.4M | ---- | 1,183.33%195K | ---- | -100.18%-18K |
| -Impairment of trade receivables (reversal) | ---- | -84.00%16K | ---- | 900.00%100K | ---- | 183.33%10K | ---- | -129.27%-12K | ---- | --41K |
| -Other impairments and provisions | ---- | 125.45%505K | ---- | -83.85%224K | ---- | 570.05%1.39M | ---- | 450.85%207K | ---- | -100.64%-59K |
| Depreciation and amortization: | ---- | 11.72%162K | ---- | -22.04%145K | ---- | -44.97%186K | ---- | 2.74%338K | ---- | -89.52%329K |
| Financial expense | ---- | 27.37%3.93M | ---- | 138.52%3.08M | ---- | 124.87%1.29M | ---- | 187.50%575K | ---- | 0.50%200K |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.71M |
| Operating profit before the change of operating capital | ---- | -22.05%-21.27M | ---- | -11.43%-17.43M | ---- | -36.41%-15.64M | ---- | 39.57%-11.46M | ---- | -29.03%-18.97M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 121.31%135K | ---- | 210.91%61K | ---- | -175.34%-55K | ---- | -25.51%73K | ---- | -4.85%98K |
| Accounts receivable (increase)decrease | ---- | -40.49%1.11M | ---- | 434.88%1.87M | ---- | -115.39%-559K | ---- | 292.43%3.63M | ---- | -123.49%-1.89M |
| Accounts payable increase (decrease) | ---- | 345.92%2.95M | ---- | 203.44%662K | ---- | 46.84%-640K | ---- | 6.52%-1.2M | ---- | 69.17%-1.29M |
| Special items for working capital changes | ---- | 115.66%269K | ---- | -947.56%-1.72M | ---- | -120.55%-164K | ---- | -43.68%798K | ---- | 266.12%1.42M |
| Cash from business operations | -3.22%-8.34M | -1.50%-16.8M | 7.57%-8.08M | 2.97%-16.55M | -12.85%-8.75M | -108.92%-17.06M | -158.08%-7.75M | 60.43%-8.16M | 71.45%-3M | -77.99%-20.63M |
| Hong Kong profits tax paid | ---- | 9.52%-19K | ---- | -142.86%-21K | ---- | --49K | --68K | ---- | ---- | -118.34%-53K |
| Interest paid - operating | 8.60%-1.74M | ---- | -48.48%-1.91M | ---- | -304.09%-1.29M | ---- | 2.15%-318K | ---- | -301.23%-325K | ---- |
| Special items of business | ---- | -27.37%-3.93M | ---- | -138.52%-3.08M | ---- | -124.87%-1.29M | ---- | -187.50%-575K | ---- | -0.50%-200K |
| Net cash from operations | -0.96%-10.09M | -5.55%-20.75M | 0.39%-9.99M | -7.40%-19.65M | -25.39%-10.03M | -109.41%-18.3M | -140.38%-8M | 58.15%-8.74M | 68.60%-3.33M | -81.58%-20.88M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -45.97%67K | 39.51%226K | 342.86%124K | 422.58%162K | 1,300.00%28K | 138.46%31K | -77.78%2K | -56.67%13K | 80.00%9K | -83.24%30K |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -29.17%408K | ---- | -45.30%576K |
| Loan receivable (increase) decrease | ---250K | ---- | ---- | 0.00%-250K | ---- | ---250K | ---250K | ---- | ---- | ---- |
| Purchase of fixed assets | -75.68%-65K | 46.58%-39K | 9.76%-37K | 45.93%-73K | 35.94%-41K | -237.50%-135K | -60.00%-64K | 81.57%-40K | 2.44%-40K | 57.20%-217K |
| Purchase of intangible assets | ---- | ---- | ---362K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --12.32M |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---250K |
| Net cash from investment operations | 9.82%-248K | 216.15%187K | -2,015.38%-275K | 54.52%-161K | 95.83%-13K | -192.91%-354K | -906.45%-312K | -96.94%381K | -100.26%-31K | 1,529.02%12.46M |
| Net cash before financing | -0.67%-10.34M | -3.75%-20.56M | -2.22%-10.27M | -6.22%-19.82M | -20.84%-10.04M | -123.19%-18.65M | -147.45%-8.31M | 0.76%-8.36M | -333.75%-3.36M | 21.55%-8.42M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 0.00%40M | -11.11%80M | -11.11%40M | -21.74%90M | -35.71%45M | -58.93%115M | -61.11%70M | 143.48%280M | 1,464.67%180M | --115M |
| Refund | 0.00%-30M | 22.08%-60M | 25.00%-30M | 48.67%-77M | 42.86%-40M | 49.15%-150M | 61.11%-70M | ---295M | ---180M | ---- |
| Net cash from financing operations | -3.51%9.97M | 54.09%19.93M | 108.14%10.33M | 136.88%12.94M | 10,886.96%4.96M | -113.16%-35.07M | 93.44%-46K | -114.48%-16.45M | -106.47%-701K | 5,435.02%113.64M |
| Effect of rate | -266.67%-15K | 75.00%-5K | 190.00%9K | 61.54%-20K | 76.19%-10K | -372.73%-52K | -700.00%-42K | 89.81%-11K | 109.72%7K | -10,700.00%-108K |
| Net Cash | -708.20%-371K | 90.89%-627K | 101.20%61K | 87.19%-6.88M | 39.20%-5.08M | -116.54%-53.73M | -105.86%-8.36M | -123.58%-24.81M | -133.10%-4.06M | 917.77%105.21M |
| Begining period cash | -2.14%28.95M | -18.91%29.58M | -18.91%29.58M | -59.58%36.48M | -59.58%36.48M | -21.57%90.26M | -21.57%90.26M | 1,053.59%115.08M | 1,053.59%115.08M | -56.33%9.98M |
| Cash at the end | -3.67%28.56M | -2.14%28.95M | -5.54%29.65M | -18.91%29.58M | -61.66%31.39M | -59.58%36.48M | -26.27%81.86M | -21.57%90.26M | 400.83%111.03M | 1,053.59%115.08M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unaudited opinion | -- | Unaudited opinion | -- | Unaudited opinion | -- | Unaudited opinion | -- | Unaudited opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.